Zimmer Biomet Looks to Rekindle Knee Replacement Growth

While Zimmer Biomet remains the dominant player in the knee replacement market, its growth in the segment has plateaued in recent years. We expect the company to generate $2.7 billion in sales for 2022, the same amount it achieved in 2016.

Over that same period, Stryker’s knee replacement implant sales consistently grew in the...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us